http://rdf.ncbi.nlm.nih.gov/pubchem/patent/HR-P20110654-T1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_116c851e729089df9a427027272fa290
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D493-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-357
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D323-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D313-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D321-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-357
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D493-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
filingDate 2011-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cf6dd0e956ac260e15a5e7f381fe0172
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f79bbf39e0d0806f8b92016d04bf5151
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d5b3c77c823a69265b3c2af6fccfa1d0
publicationDate 2011-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber HR-P20110654-T1
titleOfInvention DIMERS OF ARTEMISININ DERIVATIVES, THEIR PRODUCTION AND USE IN THERAPY
abstract Anticancer product of formula (I): characterized in that: a) A is a divalent group selected from -S-, -SO-, -SO2-, -NH-, -N (CH2-C (O) O-CH2 -CH 3) - or -N (CH 2 -COOH) -, epoxide, (C 1 -C 6) alkylene, -NHCO- or 1,2,3-triazole; b) X1 and X2 are the same and are O; c) n1 and n2 are the same or different and have the value 1, 2, 3 or 4; in the form of a base or of an addition salt with an acid, and in the form of a hydrate or of a solvate. The patent contains 11 more patent claims.
priorityDate 2006-04-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68827
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID406908050
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397365
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67516
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506145

Total number of triples: 33.